Back to search
FDAFDA · Food and drugs·Recall number D-0058-2025

Aspirin Chewable tablet 81 mg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-129-01

Published November 27, 2024 · Recall initiated: November 11, 2024

Summary

FDA records drug Class II recall D-0058-2025, published November 27, 2024 and initiated November 11, 2024. Recalling firm: Safecor Health, LLC; Status: Ongoing; Reported quantity: 1470 boxes; Lot: Lot# 24A0061, exp. date 05/23/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

What to do

Voluntary: Firm initiated · Letter

Get an email if ASPIRIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ASPIRIN
Manufacturer
Safecor Health, LLC
Distributor
USA nationwide.
Lot
Lot# 24A0061, exp. date 05/23/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Aspirin Chewable tablet 81 mg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-129-01 recalled?

Yes. FDA published recall D-0058-2025 on November 27, 2024. Reported hazard: cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ASPIRIN.